Skip to content

Vericel VCEL Amortization expense related to capitalized debt issuance costs

Amortization expense related to capitalized debt issuance costs at other companies

LeMaitre Vascular logo
LeMaitre VascularLMAT

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.13B-26.8%

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's amortization expense related to capitalized debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's amortization expense related to capitalized debt issuance costs?
Vericel (VCEL) reported amortization expense related to capitalized debt issuance costs of $54K in Q1 2026.
How has Vericel's amortization expense related to capitalized debt issuance costs changed year-over-year?
Vericel's amortization expense related to capitalized debt issuance costs decreased by 0.0% year-over-year, from $54K to $54K.
What is the long-term trend for Vericel's amortization expense related to capitalized debt issuance costs?
Over 3 years (2022 to 2025), Vericel's amortization expense related to capitalized debt issuance costs has grown at a 33.7% compound annual growth rate (CAGR), from $90K to $215K.